Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-035564
Filing Date
2025-03-07
Accepted
2025-03-07 16:31:29
Documents
105
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ubx-20241231.htm   iXBRL 10-K 3923740
2 EX-10.33 ubx-ex10_33.htm EX-10.33 139134
3 EX-19.1 ubx-ex19_1.htm EX-19.1 169775
4 EX-23.1 ubx-ex23_1.htm EX-23.1 8937
5 EX-31.1 ubx-ex31_1.htm EX-31.1 17652
6 EX-31.2 ubx-ex31_2.htm EX-31.2 17661
7 EX-32.1 ubx-ex32_1.htm EX-32.1 15088
8 GRAPHIC img60655937_0.jpg GRAPHIC 227387
9 GRAPHIC img60655937_1.jpg GRAPHIC 265625
10 GRAPHIC img60655937_2.jpg GRAPHIC 44421
11 GRAPHIC img60655937_3.jpg GRAPHIC 64903
12 GRAPHIC img60655937_4.jpg GRAPHIC 33467
13 GRAPHIC img60655937_5.jpg GRAPHIC 49286
14 GRAPHIC img60655937_6.jpg GRAPHIC 58635
15 GRAPHIC img60655937_7.jpg GRAPHIC 85464
16 GRAPHIC img60655937_8.jpg GRAPHIC 221467
17 GRAPHIC img60655937_9.jpg GRAPHIC 140275
  Complete submission text file 0000950170-25-035564.txt   19380971

Data Files

Seq Description Document Type Size
18 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ubx-20241231.xsd EX-101.SCH 2092814
108 EXTRACTED XBRL INSTANCE DOCUMENT ubx-20241231_htm.xml XML 3129303
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

EIN.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38470 | Film No.: 25720618
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)